In vitro affinity maturation of human GM-CSF antibodies by targeted CDR-diversification

抗体 亲和力成熟 细胞因子 生物 受体 体外 体细胞突变 免疫系统 免疫学 分子生物学 细胞生物学 B细胞 生物化学
作者
Stefan Steidl,Olaf Ratsch,Bodo Brocks,Manuela Dürr,Elisabeth Thomassen-Wolf
出处
期刊:Molecular Immunology [Elsevier]
卷期号:46 (1): 135-144 被引量:85
标识
DOI:10.1016/j.molimm.2008.07.013
摘要

The mammalian immune system applies somatic hypermutation to select for antibodies with improved dissociation rates in vivo up to an intrinsic limit, previously termed as affinity ceiling. However, for certain therapeutic applications it may be desirable to further improve antibody affinities beyond that limit. In this study the selection of antibodies specific for the pro-inflammatory cytokine granulocyte-macrophage colony-stimulating factor (GM-CSF) from the HuCAL GOLD human antibody library is described. In order to increase affinity and also functional activity, in vitro affinity maturation of a pool of lead Fab candidates was carried out. CDR-L3 and parallel CDR-H2 diversification using trinucleotide consensus cassettes were followed by the combination of optimized CDR-L3 and CDR-H2 leading to a 5000-fold improved affinity finally reaching a KD of 400 fM. Cytokine neutralizing potential of MOR04357 was evaluated in a TF-1 proliferation assay. Along with affinity optimization a 2000-fold increase in potency was observed compared to the parental antibody. Due to species cross-reactivity MOR04357 also blocks rat GM-CSF induced proliferation of FDCP-1 cells. Receptor inhibition studies showed that MOR04357 prevents the interaction of GM-CSF with the GM-CSF receptor alpha chain. As a consequence this leads to a blockade in signal transduction as measured by abolished STAT5 phosphorylation in the presence of GM-CSF and antibody. Due to its pro-inflammatory role GM-CSF has been implicated in the pathophysiology of inflammatory diseases like rheumatoid arthritis or asthma. Based on the mode of action described herein MOR04357 shows favourable antibody features as a potential drug candidate.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
MiserDespera应助DChen采纳,获得100
2秒前
3秒前
聪慧语风发布了新的文献求助30
3秒前
3秒前
3秒前
星辰大海应助777777777采纳,获得10
7秒前
上官若男应助zjj970654859采纳,获得10
7秒前
7秒前
8秒前
bkagyin应助科研通管家采纳,获得10
8秒前
FashionBoy应助科研通管家采纳,获得10
8秒前
完美世界应助科研通管家采纳,获得10
8秒前
研友_VZG7GZ应助科研通管家采纳,获得10
8秒前
斯文败类应助科研通管家采纳,获得10
8秒前
顾矜应助科研通管家采纳,获得10
8秒前
共享精神应助科研通管家采纳,获得10
8秒前
烟花应助科研通管家采纳,获得10
8秒前
852应助科研通管家采纳,获得10
8秒前
千冬发布了新的文献求助10
9秒前
Vivian完成签到,获得积分10
9秒前
niko发布了新的文献求助10
9秒前
datasushi完成签到,获得积分20
10秒前
田様应助带鱼的笔芯采纳,获得10
10秒前
大模型应助傅双庆采纳,获得10
11秒前
小巧问柳完成签到,获得积分10
11秒前
11秒前
大力的新蕾完成签到,获得积分10
12秒前
hyy完成签到,获得积分10
13秒前
aa121599完成签到,获得积分20
13秒前
yuyulovewei发布了新的文献求助10
14秒前
15秒前
17秒前
学海无涯发布了新的文献求助10
17秒前
隐形的冰海完成签到,获得积分20
20秒前
葡萄完成签到 ,获得积分10
20秒前
21秒前
21秒前
aa121599关注了科研通微信公众号
22秒前
zjj970654859发布了新的文献求助10
23秒前
23秒前
高分求助中
Spray / Wall-interaction Modelling by Dimensionless Data Analysis 2000
ALA生合成不全マウスでの糖代謝異常の分子機構解析 520
安全防范技术与工程 500
Mathematics and Finite Element Discretizations of Incompressible Navier—Stokes Flows 500
A real-time energy management strategy based on fuzzy control and ECMS for PHEVs 400
2024 Medicinal Chemistry Reviews 400
Актуализированная стратиграфическая схема триасовых отложений Прикаспийского региона. Объяснительная записка 360
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3191563
求助须知:如何正确求助?哪些是违规求助? 2840946
关于积分的说明 8030661
捐赠科研通 2504385
什么是DOI,文献DOI怎么找? 1337606
科研通“疑难数据库(出版商)”最低求助积分说明 638159
邀请新用户注册赠送积分活动 606675